Novartis says trial results back Tasigna drug
Filed under: drug rehab treatment options
Other data also presented at ASH showed that Novartis' drug Jakavi – which gained EU approval in August – significantly reduced the disease burden in patients with myelofibrosis, a rare blood cancer with limited treatment options. Follow up data from a …
Read more on Reuters
Possible hemophilia drug has good results: Baxter
Filed under: drug rehab treatment options
The medical product company's BAX 326–its investigational recombinant factor IX protein for the treatment and prophylaxis of bleeding episodes for patients with hemophilia B over 12 years of age–was recently granted orphan-drug designation by the U.S …
Read more on MarketWatch
Ibrutinib Effective and Safe Treatment Option in CLL
Filed under: drug rehab treatment options
ATLANTA, Georgia — A novel investigational therapeutic agent appears to be an effective and safe treatment option for patients with chronic lymphocytic leukemia (CLL). According to 2 new … With other drugs, we tend to see much higher rates," he added.
Read more on Medscape